Evidence map›Paper›PMID 31423249›Full record

ArticleOncology letters2019

Cervical cancer evaluated with integrated

Jing Gong, Nan Wang, Lihua Bian, Min Wang, Mingxia Ye, Na Wen, Meng Fu, Wensheng Fan, Yuanguang Meng

Abstract read
In one paragraph

Article in Oncology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Precision matters: the value of PET/CT and PET/MRI in the clinical management of cervical cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Review
  3. Application ofDiagnostics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing GongDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Nan WangDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Lihua BianDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Min WangDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Mingxia YeDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Na WenDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Meng FuDepartment of Obstetrics and Gynecology, Haidian Maternal and Child Health Hospital, Beijing 100080, P.R. China.
Wensheng FanDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Yuanguang MengDepartment of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing 100853, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study aimed to evaluate the correlation between maximum standardized uptake value (SUV

Indexed as

cervical cancerhistological gradeInternational Federation of Gynecology and Obstetrics stagelymph node metastasismaximum standardized uptake valueminimum apparent diffusion coefficientpositron emission tomography/magnetic resonance imaging

Identifiers

PMID31423249
PMCPMC6614720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.